Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Parasitol Res ; 117(5): 1647-1655, 2018 May.
Artículo en Inglés | MEDLINE | ID: mdl-29550999

RESUMEN

Megaesophagus is one of the major manifestations of the chronic phase of Chagas disease. Its primary symptom is generally dysphagia due to disturbance in the lower esophageal sphincter. Microscopically, the affected organ presents denervation, which has been considered as consequence of an inflammatory process that begins at the acute phase and persists in the chronic phase. Inflammatory infiltrates are composed of lymphocytes, macrophages, natural killer cells, mast cells, and eosinophils. In this study, we evaluated the immunoreactivity of nerve growth factor (NGF), and of its receptor tropomyosin receptor kinase A (TrkA), molecules that are well known for having a relevant role in neuroimmune communication in the gastrointestinal tract. Esophageal samples obtained via autopsy or surgery procedures from six noninfected individuals, six infected individuals without megaesophagus, and six infected individuals with megaesophagus were analyzed. Infected individuals without megaesophagus presented increased numbers of NGF immunoreactive (IR) mast cells and increased areas of TrkA-IR epithelial cells and inner muscle cells. Infected individuals with megaesophagus showed increased numbers of NGF-IR eosinophils and mast cells, TrkA-IR eosinophils and mast cells, increased area of NGF-IR epithelial cells, and increased areas of TrkA-IR epithelials cells and inner muscle cells. The data presented here point to the participation of NGF and its TrkA receptor in the pathology of chagasic megaesophagus.


Asunto(s)
Enfermedad de Chagas/patología , Acalasia del Esófago/patología , Factor de Crecimiento Nervioso/inmunología , Receptor trkA/inmunología , Trypanosoma cruzi/patogenicidad , Recuento de Células , Enfermedad de Chagas/parasitología , Eosinófilos/inmunología , Acalasia del Esófago/parasitología , Esófago/parasitología , Esófago/patología , Femenino , Humanos , Macrófagos/inmunología , Masculino , Mastocitos/inmunología , Persona de Mediana Edad , Células Musculares/inmunología , Neuronas/metabolismo , Carga de Parásitos , Proteínas Quinasas , Tropomiosina/metabolismo , Trypanosoma cruzi/aislamiento & purificación
2.
Parasitol Res ; 117(4): 1147-1158, 2018 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-29470711

RESUMEN

Chagas disease is an infection caused by the parasite Trypanosoma cruzi that affects millions of people worldwide and is endemic in Latin America. Megacolon is the most frequent complication of the digestive chronic form and happens due to lesions of the enteric nervous system. The neuronal lesions seem to initiate in the acute phase and persist during the chronic phase, albeit the mechanisms involved in this process are still debated. Among the cells of the immune system possibly involved in this pathological process is the mast cell (MC) due to its well-known role in the bi-directional communication between the immune and nervous systems. Using ultrastructural analysis, we found an increased number of degranulated MCs in close proximity to nerve fibers in infected patients when compared with uninfected controls. We also immunostained MCs for the two pro-inflammatory molecules tryptase and chymase, the first being also important in neuronal death. The number of MCs immunostained for tryptase or chymase was increased in patients with megacolon, whereas increased tryptase staining was additionally observed in patients without megacolon. Moreover, we detected the expression of the tryptase receptor PAR2 in neurons of the enteric nervous system, which correlated to the tryptase staining results. Altogether, the data presented herein point to the participation of MCs on the denervation process that occurs in the development of T. cruzi-induced megacolon.


Asunto(s)
Enfermedad de Chagas/inmunología , Colon/patología , Sistema Nervioso Entérico/inmunología , Mastocitos/inmunología , Megacolon/patología , Neuroinmunomodulación/fisiología , Trypanosoma cruzi/inmunología , Anciano , Animales , Enfermedad de Chagas/parasitología , Quimasas/inmunología , Escarabajos , Colon/parasitología , Sistema Nervioso Entérico/parasitología , Femenino , Humanos , Masculino , Megacolon/parasitología , Persona de Mediana Edad , Neuronas/metabolismo , Receptor PAR-2 , Receptores Acoplados a Proteínas G/metabolismo , Triptasas/inmunología
3.
Adv Rheumatol ; 58(1): 21, 2018 Aug 03.
Artículo en Inglés | MEDLINE | ID: mdl-30657084

RESUMEN

BACKGROUND: Fibromyalgia (FM) is a syndrome characterized by widespread chronic pain associated to other symptoms, such as: fatigue, anxiety, depression and sleep disorders. Health education programs (HEP) have emerged as good non-pharmacological strategies to treat it. However, it is still not clear if the benefits are only subjective, or it has also objective impacts on immune and or neuroendocrine systems. METHODS: Fifty-eight fibromyalgia women were randomly allocated in experimental group (n = 27) or control group (n = 31). The experimental group was submitted to HEP treatment for 11 weeks, while control group did not receive intervention at the same period. All data were collected at zero and 11th week by a blinded researcher. The statistical analysis were made in GraphPad Prism software (version 5.0) with significant level adjusted for α = 0.05. RESULTS: Forty-four patients concluded the full study, 21 in the experimental group and 23 in the control group. Intragroup and intergroup analysis revealed that treatment induced significant increases of IL-4 plasma levels, anti-inflammatory cytokine/inflammatory cytokine ratio (AC/IC ratio), salivary cortisol levels, in addition to significant decreases on FIQ scores. Intergroup variation analyses revealed also significant increases of IL-10 plasma levels. CONCLUSION: The results presented suggest that this kind of HEP could induce subjective and objective changes (immune and neuroendocrine), that could explain, at least in part the improvement of fibromyalgia patient's health status. (Clinical Trial Registration Number - ReBEC - RBR-5tdnbr).


Asunto(s)
Citocinas/sangre , Fibromialgia/sangre , Fibromialgia/terapia , Educación en Salud , Hidrocortisona/análisis , Educación del Paciente como Asunto , Saliva/química , Femenino , Educación en Salud/métodos , Estado de Salud , Humanos , Interleucina-10/sangre , Interleucina-17/sangre , Interleucina-2/sangre , Interleucina-4/sangre , Interleucina-6/sangre , Persona de Mediana Edad , Factor de Necrosis Tumoral alfa/sangre
4.
Parasitol Res ; 114(5): 1847-56, 2015 May.
Artículo en Inglés | MEDLINE | ID: mdl-25711147

RESUMEN

Megacolon is frequently observed in patients who develop the digestive form of Chagas disease. It is characterized by dilation of the rectum-sigmoid portion and thickening of the colon wall. Microscopically, the affected organ presents denervation, which has been considered as consequence of an inflammatory process that begins at the acute phase and persists in the chronic phase of infection. Inflammatory infiltrates are composed of lymphocytes, macrophages, natural killer cells, mast cells, and eosinophils. In this study, we hypothesized that mast cells producing tryptase could influence the migration and the activation of eosinophils at the site, thereby contributing to the immunopathology of the chronic phase. We seek evidence of interactions between mast cells and eosinophils through (1) evaluation of eosinophils, regarding the expression of PAR2, a tryptase receptor; (2) correlation analysis between densities of mast cells and eosinophils; and (3) ultrastructural studies. The electron microscopy studies revealed signs of activation of mast cells and eosinophils, as well as physical interaction between these cells. Immunohistochemistry and correlation analyses point to the participation of tryptase immunoreactive mast cells in the migration and/or survival of eosinophils at the affected organ.


Asunto(s)
Enfermedad de Chagas/inmunología , Eosinófilos/inmunología , Mastocitos/inmunología , Trypanosoma cruzi/inmunología , Triptasas/inmunología , Adulto , Anciano , Enfermedad de Chagas/parasitología , Colon/inmunología , Colon/parasitología , Eosinófilos/ultraestructura , Femenino , Humanos , Inmunohistoquímica , Macrófagos/inmunología , Macrófagos/ultraestructura , Masculino , Mastocitos/ultraestructura , Persona de Mediana Edad
5.
Clin Exp Rheumatol ; 33(1 Suppl 88): S14-9, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-24565062

RESUMEN

OBJECTIVES: The aim of this study was to evaluate the levels of 6-sulphatoxymelatonin (6-SMT) in the urine of patients with fibromyalgia (FM) and correlate them with the score obtained by these patients in four clinical assessment instruments. METHODS: Fifty-eight women with primary FM and 39 healthy women matched for age and body mass index were included in the study sample. The levels of 6-SMT were evaluated in urine collected from 8 pm until 8 am the next day by the immunosorbent assay. For the clinical evaluation we used the Fibromyalgia Impact Questionnaire (FIQ); Pittsburg Sleep Quality Index (PSQI); Medical Outcomes Study 36-item Short-Form Health Survey (SF-36) and Satisfaction with Life Scale (SWLS). Data normality was assessed using the Kolmogorov-Smirnov test, the differences between groups by means of the Mann-Whitney test and correlation analysis by Spearman's correlation test. RESULTS: The levels of 6-SMT in the urine of patients with FM were significantly lower than those found in the urine of healthy controls. The score obtained by patients with FM was significantly different from the score achieved by the healthy controls in the four assessment tools. However, no significant correlation between urinary levels of 6-SMT and scores on assessment instruments was observed. CONCLUSIONS: The results of this study do not discard the involvement of melatonin in the pathophysiology of FM, but may suggest that changes in melatonin levels when associated with other neuroimmunoendocrine changes may impact directly and negatively on the manifestation of symptoms that make up the clinical picture of FM.


Asunto(s)
Fibromialgia/orina , Melatonina/análogos & derivados , Adulto , Biomarcadores/orina , Brasil , Estudios de Casos y Controles , Regulación hacia Abajo , Ensayo de Inmunoadsorción Enzimática , Femenino , Fibromialgia/diagnóstico , Fibromialgia/fisiopatología , Fibromialgia/psicología , Estado de Salud , Humanos , Melatonina/orina , Persona de Mediana Edad , Satisfacción del Paciente , Valor Predictivo de las Pruebas , Calidad de Vida , Índice de Severidad de la Enfermedad , Sueño , Estadísticas no Paramétricas , Encuestas y Cuestionarios , Síndrome , Urinálisis
6.
Hum Immunol ; 75(4): 302-5, 2014 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-24530752

RESUMEN

Tryptase and chymase are mast cell (MC)-specific proteases, which influence in the activation of inflammatory cells. In this study, we quantified tryptase- or chymase-expressing MCs in the oesophaguses of Chagas patients, and searched for a correlation between those data with area of nerve fibres that expressed either PGP9.5 (pan-marker) or vasoactive intestinal polypeptide (VIP), which is a neuromediator that has anti-inflammatory activity. Samples from the oesophaguses of 14 individuals Trypanosoma cruzi-infected and from six uninfected individuals were analysed by immunohistochemistry. It was demonstrated that the number of tryptase-IR MCs in infected individuals increased when compared with controls, regardless of whether the individuals had megaoesophagus, whereas the number of chymase-IR MCs increased only in infected individuals without megaoesophagus. Negative correlations were observed between tryptase-IR MCs and the density of nerve fibres that expressed VIP or PGP 9.5-IR. The participation of chymase and tryptase in this type of immunopathology is discussed.


Asunto(s)
Enfermedad de Chagas/complicaciones , Acalasia del Esófago/etiología , Trypanosoma cruzi/inmunología , Adulto , Anciano , Acalasia del Esófago/enzimología , Acalasia del Esófago/patología , Humanos , Inmunohistoquímica , Mastocitos/enzimología , Mastocitos/inmunología , Persona de Mediana Edad , Péptido Hidrolasas/metabolismo
7.
Hum Pathol ; 41(4): 528-34, 2010 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-20004942

RESUMEN

Chagas disease is caused by infestation with the parasite Trypanosoma cruzi, and some patients who are serologically positive develop chronic megaesophagus, whereas others are symptom-free. Gastrointestinal form of Chagas disease involves an inflammatory invasion of the enteric plexuses and degeneration of enteric neurons and previous works related that enteroglial cells would be involved in enteric inflammatory responses. Because of this, the aims of this study were to determine the relation of enteroglial cells with the denervation process in chagasic patients with and without megaesophagus and seronegative individuals. Our results indicated that the innervation of the esophageal muscle was substantially reduced in patients with megaesophagus, but asymptomatic seropositive subjects were not different to seronegative controls. Besides, patients with megaesophagus had significant decreased of enteroglial cells labeled with S-100 and glial fibrillary acidic protein, whereas patients without megaesophagus presented an increased of both labels. We believe that enteroglial cells would operate a mechanism of defense in the enteric nervous system against the Trypanosoma cruzi infection, which could prevent the organ denervation and preserve the esophagus function.


Asunto(s)
Enfermedad de Chagas/patología , Sistema Nervioso Entérico/patología , Acalasia del Esófago/patología , Esófago/inervación , Neuroglía/patología , Enfermedad de Chagas/complicaciones , Enfermedad de Chagas/fisiopatología , Acalasia del Esófago/complicaciones , Acalasia del Esófago/fisiopatología , Esofagitis/inmunología , Esofagitis/patología , Esófago/inmunología , Proteína Ácida Fibrilar de la Glía/metabolismo , Humanos , Persona de Mediana Edad , Proteínas S100/metabolismo
9.
Hum Immunol ; 70(1): 65-7, 2009 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-19022313

RESUMEN

Patients with Chagas's disease in the chronic phase regularly present with the chagasic megacolon. This form is characterized by inflammation, neuronal destruction, and organ dilatation. Chagasic patients with megacolon always present with inflammatory process near the enteric plexuses of the colon, as previously demonstrated. The aim of this study is to characterize the presence and distribution of Foxp3(+) cells in the muscle layers and neuronal plexuses area of the colon from chagasic patients with and without megacolon. Our results demonstrated that chagasic patients without megacolon presented with an increased concentration of Foxp3(+) cells in all colon layers compared with chagasic patients with megacolon and noninfected individuals. These cells were situated mainly near the blood vessels and rarely were associated with the inflammatory foci. We believe that the presence of Foxp3(+) cells may help to control the inflammatory process through the management of lymphocyte migration and, consequently, prevent neuronal destruction and chagasic megacolon development.


Asunto(s)
Enfermedad de Chagas/patología , Colon/patología , Sistema Nervioso Entérico/patología , Factores de Transcripción Forkhead/metabolismo , Megacolon/patología , Anciano , Enfermedad de Chagas/complicaciones , Enfermedad de Chagas/metabolismo , Colon/metabolismo , Sistema Nervioso Entérico/metabolismo , Femenino , Humanos , Masculino , Megacolon/complicaciones , Megacolon/metabolismo , Persona de Mediana Edad
11.
Hum Pathol ; 38(8): 1256-64, 2007 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-17490721

RESUMEN

After acute infestation with the Chagas disease parasite, Trypanosoma cruzi, some patients who are serologically positive develop chronic megacolon and megaesophagus, whereas others are symptom-free. Chagas disease with gastrointestinal involvement involves an inflammatory invasion of the enteric plexuses and degeneration of enteric neurons. It is known that glial cells can be involved in enteric inflammatory responses. The aims were to determine the nature of any difference in lymphocytic invasion, enteric neurons, and enteric glial cells in seropositive individuals with and without megacolon. We have compared colonic tissue from serologically positive individuals with and without symptoms and from seronegative controls. Subjects with megacolon had significantly more CD-57 natural killer cells and TIA-1 cytotoxic lymphocytes within enteric ganglia, but numbers of CD-3 and CD-20 immunoreactive cells were not significantly elevated. The innervation of the muscle was substantially reduced to about 20% in megacolon, but asymptomatic seropositive subjects were not different to seronegative controls. Glial cell loss occurred equally in symptomatic and unaffected seropositive subjects, although the proportion with glial fibrillary acidic protein was greater in seropositive, nonsymptomatic subjects. Development of megacolon after acute infection with T cruzi is associated with maintained invasion of enteric ganglia with cytotoxic T cells and loss of muscle innervation, but changes in glial cell numbers are not associated with progression of enteric neuropathy.


Asunto(s)
Enfermedad de Chagas/patología , Colon/patología , Megacolon/patología , Plexo Mientérico/patología , Neuroglía/patología , Plexo Submucoso/patología , Biomarcadores/metabolismo , Recuento de Células , Enfermedad de Chagas/complicaciones , Enfermedad de Chagas/inmunología , Colon/inervación , Técnica del Anticuerpo Fluorescente Indirecta , Humanos , Técnicas para Inmunoenzimas , Células Asesinas Naturales/metabolismo , Células Asesinas Naturales/patología , Subgrupos Linfocitarios/metabolismo , Subgrupos Linfocitarios/patología , Megacolon/inmunología , Megacolon/parasitología , Plexo Mientérico/inmunología , Neuroglía/inmunología , Neuroglía/metabolismo , Proteínas de Unión a Poli(A)/metabolismo , Plexo Submucoso/inmunología , Antígeno Intracelular 1 de las Células T , Linfocitos T Citotóxicos/metabolismo , Linfocitos T Citotóxicos/patología
12.
Trans R Soc Trop Med Hyg ; 97(3): 308-9, 2003.
Artículo en Inglés | MEDLINE | ID: mdl-15228249

RESUMEN

We have previously amplified Trypanosoma cruzi DNA by polymerase chain reaction (PCR) from the oesophagus of chagasic patients with megaoesophagus, whilst immunohistochemical analysis failed to detect T. cruzi antigen in the oesophagus of chagasic patients without megaoesophagus. During 2000-01, we tested for the presence of T. cruzi DNA in oesophageal tissue from 9 chronic chagasic patients without megaoesophagus and 5 were positive by PCR, which suggests that other factors, besides simply the presence of the parasite, should be considered in the understanding of the pathogenesis of megaoesophagus.


Asunto(s)
Enfermedad de Chagas/parasitología , Acalasia del Esófago/parasitología , Esófago/parasitología , Trypanosoma cruzi/aislamiento & purificación , Animales , Enfermedad de Chagas/complicaciones , Enfermedad Crónica , ADN Protozoario/análisis , Humanos , Reacción en Cadena de la Polimerasa/métodos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...